CRISPR Therapeutics Highlights Strategic Priorities and 2024 Outlook
Go back to CRISPR Therapeutics Highlights Strategic Priorities and 2024 Outlook| (NASDAQ: CRSP) | Delayed: 52.78 +0.52 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.26 | 52 Week High | $18.88 | |||
| Open | $52.35 | 52 Week Low | $13.75 | |||
| Day High | $53.21 | P/E | N/A | |||
| Day Low | $52.19 | EPS | $0.00 | |||
| Volume | 118,550 | |||||

